CTOs on the Move

OrphoMed Inc

www.orphomed.com

 
OrphoMed is a San Francisco based clinical stage pharmaceutical company focused on the development of novel first-in-class dimer conjugates with superior therapeutic profiles. The company is leveraging its proprietary dimer platform technology to address the issues of visceral hypersensitivity and hypermotility in functional gastrointestinal disorders. OrphoMed dimers are protected by composition of matter and method of use patents.
  • Number of Employees: 0-25
  • Annual Revenue: $0-1 Million

Executives

Name Title Contact Details

Funding

OrphoMed Inc raised $39M on 05/24/2017

Similar Companies

Axcan Pharma Inc

Axcan Pharma Inc is a Birmingham, AL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Trilogy Behavioral Healthcare

Trilogys Mission is to support people in their recovery from mental illness by helping them discover and reclaim their capabilities and well being.

Saranas

Early Bird is the first and only FDA-approved bleed detection system for peri and post-procedural monitoring of endovascular procedures.

Meyer Pharmaceuticals (Main)

Meyer Pharmaceuticals (Main) is a Irvine, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Medico Labs Inc

Medico Labs Inc is a Trenton, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.